ConductScience.org, home

Paper197883

The low-density lipoprotein pathway and its relation to atherosclerosis.

Goldstein JL and 1 other. Annu Rev Biochem, 1977. Cited by 2,363 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. The low-density lipoprotein pathway and its relation to atherosclerosis. Papers, record 197883. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/197883

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The low-density lipoprotein pathway and its relation to atherosclerosis.
PubMed
Journal
Annu Rev Biochem
PubMed
Year
1977
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
2,363
iCite
Relative citation ratio, by iCite
63.8
iCite
Revised in PubMed
2022-03-16
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Goldstein JLJ L
2Brown MSM S

Source PubMed

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
ArteriosclerosisMajor topic
Lipoproteins, LDLMajor topic
Aorta
Apolipoproteins
Cholesterol
Cholesterol Esters
Endocytosis
Fibroblasts
Humans
Intestinal Mucosa
Kinetics
Liver
Models, Biological
Molecular Weight
Protein Binding
Receptors, Drug

Source PubMed

Cited by429

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2,363 citations.

PMIDTitleJournalYearIn PapersSource
42,852,022Rare Diseases as Engines of Biomedical Innovation: Lessons for Gene Therapy and Common Disease.Yale J Biol Med2026https://conductscience.org/library/papers/42852022PubMed
42,182,449Impaired lipoprotein secretion by APOE4 leads to lysosomal and mitochondrial dysfunction in human microglia.bioRxiv2026https://conductscience.org/library/papers/42182449PubMed
42,074,289Targeting the NLRP3 Inflammasome in Atherosclerosis: A Review of Natural Products and Their Molecular Mechanisms.Int J Mol Sci2026https://conductscience.org/library/papers/42074289PubMed
41,964,074Sex- and age-dependent mitochondrial dysfunction and cognitive impairment in a mouse model of familial hypercholesterolemia.Biol Sex Differ2026https://conductscience.org/library/papers/41964074PubMed
40,813,253Low HDL-The Challenge.Clin Med Res2025https://conductscience.org/library/papers/40813253PubMed
40,362,498The Role of Ubiquitination on Macrophages in Cardiovascular Diseases and Targeted Treatment.Int J Mol Sci2025https://conductscience.org/library/papers/40362498PubMed
39,966,374Energy metabolism in health and diseases.Signal Transduct Target Ther2025https://conductscience.org/library/papers/39966374PubMed
39,205,930Characterization of the daucosterol-lecithin complex and its impact on lipid metabolism in hyperlipidemic mice.RSC Adv2024https://conductscience.org/library/papers/39205930PubMed
38,974,714Gene editing therapy for cardiovascular diseases.MedComm (2020)2024https://conductscience.org/library/papers/38974714PubMed
38,892,201Discovering Inflammation in Atherosclerosis: Insights from Pathogenic Pathways to Clinical Practice.Int J Mol Sci2024https://conductscience.org/library/papers/38892201PubMed
38,791,422Impact of CYP2C19 Gene Variants on Long-Term Treatment with Atorvastatin in Patients with Acute Coronary Syndromes.Int J Mol Sci2024https://conductscience.org/library/papers/38791422PubMed
38,711,272Statins as anti-tumor agents: A paradigm for repurposed drugs.Cancer Rep (Hoboken)2024https://conductscience.org/library/papers/38711272PubMed
38,284,727Targeting Ferroptosis: A Novel Strategy for the Treatment of Atherosclerosis.Mini Rev Med Chem2024https://conductscience.org/library/papers/38284727PubMed
37,512,506The Role of Cholesterol in Chronic Lymphocytic Leukemia Development and Pathogenesis.Metabolites2023https://conductscience.org/library/papers/37512506PubMed
37,351,276Defining the ligand-dependent proximatome of the sigma 1 receptor.Front Cell Dev Biol2023https://conductscience.org/library/papers/37351276PubMed
37,154,584Total-, LDL-, and HDL-cholesterol, apolipoproteins, and triglycerides with risk of total and fatal prostate cancer in Black and White men in the ARIC study.Prostate2023https://conductscience.org/library/papers/37154584PubMed
36,876,496RNF130 Regulates LDLR Availability and Plasma LDL Cholesterol Levels.Circ Res2023https://conductscience.org/library/papers/36876496PubMed
36,235,012Polydatin: Pharmacological Mechanisms, Therapeutic Targets, Biological Activities, and Health Benefits.Molecules2022https://conductscience.org/library/papers/36235012PubMed
36,034,914The health effects of soy: A reference guide for health professionals.Front Nutr2022https://conductscience.org/library/papers/36034914PubMed
35,980,230Surface-modified nanotherapeutics targeting atherosclerosis.Biomater Sci2022https://conductscience.org/library/papers/35980230PubMed

See all 429 cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/197883

GET https://conductscience.org/api/papers/v1/197883/cited_by?page=2